Associations between endothelin-1 and adiponectin in chronic heart failure

Cardiology

Volumn 118, Issue 4, 2011, Pages 207-216

  Yin, Wei Hsian ^a,b   Chen, Yung Hsiang ^c   Wei, Jeng ^a   Jen, Hsu Lung ^a,b   Huang, Wen Ping ^a,b   Young, Mason Shing ^a   Chen, Der Cherng ^c   Liu, Po Len ^d  

^a CHENG HSIN GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

^d KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Adiponectin; Cardiomyocyte; Endothelin 1; Heart failure; Hypertrophy; NT proBNP

Indexed keywords

ADIPONECTIN; BRAIN NATRIURETIC PEPTIDE; ENDOTHELIN 1;

ADULT; ARTICLE; CELL CULTURE; CELL SIZE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HEART FAILURE; HEART MUSCLE CELL; HEART TRANSPLANTATION; HUMAN; HUMAN CELL; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION;

ADIPONECTIN; BODY MASS INDEX; CARDIOMEGALY; CELL SIZE; CELLS, CULTURED; ENDOTHELIN-1; FEMALE; HEART FAILURE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; MYOCARDIUM; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PROGNOSIS;

EID: 79959426382     PISSN: 00086312     EISSN: 14219751     Source Type: Journal    
DOI: 10.1159/000328780     Document Type: Article

References (34)

1. Tang CH, Chiu YC, Tan TW, Yang RS, Fu WM: Adiponectin enhances IL-6 production in human synovial fibroblast via an AdipoR1 receptor, AMPK, p38, and NF-kappa B pathway. J Immunol 2007; 179: 5483-5492.
2. Matsuzawa Y, Funahashi T, Nakamura T: Molecular mechanism of metabolic syndrome X: Contribution of adipocytokines adipocyte-derived bioactive substances. Ann NY Acad Sci 1999; 892: 146-154.
3. Scherer PE, Williams S, Fogliano M, Baldini G, Lodish HF: A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem 1995; 270: 26746-26749.
4. Kistorp C, Faber J, Galatius S, Gustafsson F, Frystyk J, Flyvbjerg A, Hildebrandt P: Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure. Circulation 2005; 112: 1756-1762. (Pubitemid 41372115)
5. Tsutamoto T, Tanaka T, Sakai H, Ishikawa C, Fujii M, Yamamoto T, et al: Total and high molecular weight adiponectin, haemodynamics, and mortality in patients with chronic heart failure. Eur Heart J 2007; 28: 1723-1730. (Pubitemid 47227093)
6. Clarke KJ, Zhong Q, Schwartz DD, Coleman ES, Kemppainen RJ, Judd RL: Regulation of adiponectin secretion by endothelin-1. Biochem Biophys Res Commun 2003; 312: 945-949. (Pubitemid 37490906)
7. Bedi D, Clarke KJ, Dennis JC, Zhong Q, Brunson BL, Morrison EE, Judd RL: Endothelin-1 inhibits adiponectin secretion through a phosphatidylinositol 4,5-bisphosphate/ actin-dependent mechanism. Biochem Biophys Res Commun 2006; 345: 332-339.
8. Juan CC, Chuang TY, Chang CL, Huang SW, Ho LT: Endothelin-1 regulates adiponectin gene expression and secretion in 3T3-L1 adipocytes via distinct signaling pathways. Endocrinology 2007; 148: 1835-1842.
9. Wang Y, Lau WB, Gao E, Tao L, Yuan Y, Li R, Wang X, Koch WJ, Ma XL: Cardiomyocyte-derived adiponectin is biologically active in protecting against myocardial ischemia-reperfusion injury. Am J Physiol Endocrinol Metab 2010; 298:E663-E670.
10. Takahashi T, Saegusa S, Sumino H, Nakahashi T, Iwai K, Morimoto S, Nojima T, Kanda T: Adiponectin, T-cadherin and tumour necrosis factor-alpha in damaged cardiomyocytes from autopsy specimens. J Int Med Res 2005; 33: 236-244. (Pubitemid 40372440)
11. Takano H, Obata J, Kodama Y, Kitta Y, Nakamura T, Mende A, Kawabata K, Saito Y, Fujioka D, Kobayashi T, Yano T, Sano K, Kugiyama K: Adiponectin is released from the heart in patients with heart failure. Int J Cardiol 2009; 132: 221-226.
12. Skurk C, Wittchen F, Suckau1 L, Witt H, Noutsias M, Fechner H, Schultheiss HP, Poller W: Description of a local cardiac adiponectin system and its deregulation in dilated cardiomyopathy. Eur Heart J 2008; 29: 1168-1180. (Pubitemid 351844892)
13. Peltonen T, Taskinen P, Napankangas J, Leskinen H, Ohtonen P, Soini Y, Juvonen T, Satta J, Vuolteenaho O, Ruskoaho H: Increase in tissue endothelin-1 and ETA receptor levels in human aortic valve stenosis. Eur Heart J 2009; 30: 242-249.
14. Cheng TH, Lin JW, Chao HH, Chen YL, Chen CH, Chan P, Liu JC: Uric acid activates extracellular signal-regulated kinases and thereafter endothelin-1 expression in rat cardiac fibroblasts. Int J Cardiol 2010; 139: 42-49.
15. Saetrum Opgaard O, Adner M, Peters TH, Xu CB, Stavenow L, Gulbenkian S, Erlinge D, Edvinsson L, Sharma HS: Endocardial expression and functional characterization of endothelin-1. Mol Cell Biochem 2001; 224: 151-158. (Pubitemid 32962661)
16. Potaczek DP, Sanak M: Endothelin-biosynthesis, function and role in cardiovascular diseases. Pol Arch Med Wewn 2002; 108: 703-714.
17. Miyauchi T, Masaki T: Pathophysiology of endothelin in the cardiovascular system. Annu Rev Physiol 1999; 61: 391-415. (Pubitemid 29143176)
18. Suzuki T, Hoshi H, Mitsui Y: Endothelin stimulates hypertrophy and contractility of neonatal rat cardiac myocytes in a serumfree medium. FEBS Lett 1990; 268: 149-151. (Pubitemid 20233853)
19. Sakai S, Miyauchi T, Kobayashi M, Yamaguchi I, Goto K, Sugishita Y: Inhibition of myocardial endothelin pathway improves longterm survival in heart failure. Nature 1996; 384: 353-355. (Pubitemid 26408515)
20. Sakai S, Miyauchi T, Yamaguchi I: Longterm endothelin receptor antagonist administration improves alterations in expression of various cardiac genes in failing myocardium of rats with heart failure. Circulation 2000; 101: 2849-2853. (Pubitemid 30396017)
21. Fujioka D, Kawabata K, Saito Y, Kobayashi T, Nakamura T, Kodama Y, Takano H, Obata JE, Kitta Y, Umetani K, Kugiyama K: Role of adiponectin receptors in endothelin-induced cellular hypertrophy in cultured cardiomyocytes and their expression in infarcted heart. Am J Physiol Heart Circ Physiol 2006; 290:H2409-H2416. (Pubitemid 43846069)
22. World Medical Association Declaration of Helsinki. Recommendations guiding physicians in biomedical research involving human subjects. Cardiovasc Res 1997; 35: 2-3.
23. Lin FY, Chen YH, Lin YW, Tsai JS, Chen JW, Wang HJ, Chen YL, Li CY, Lin SJ: The role of human antigen R, an RNA-binding protein, in mediating the stabilization of toll-like receptor 4 mRNA induced by endotoxin: A novel mechanism involved in vascular inflammation. Arterioscler Thromb Vasc Biol 2006; 26: 2622-2629.
24. Chen JW, Lin FY, Chen YH, Wu TC, Chen YL, Lin SJ: Carvedilol inhibits tumor necrosis factor-alpha-induced endothelial transcription factor activation, adhesion molecule expression, and adhesiveness to human mononuclear cells. Arterioscler Thromb Vasc Biol 2004; 24: 2075-2081.
25. Masson S, Latini R, Anand IS, Barlera S, Judd D, Salio M, Perticone F, Perini G, Tognoni G, Cohn JN, Val-HeFT investigators: The prognostic value of big endothelin-1 in more than 2,300 patients with heart failure enrolled in the Valsartan Heart Failure Trial (Val-HeFT). J Card Fail 2006; 12: 375-380. (Pubitemid 43833416)
26. Lüscher TF, Enseleit F, Pacher R, Mitrovic V, Schulze MR, Willenbrock R, Dietz R, Rousson V, Hürlimann D, Philipp S, Notter T, Noll G, Ruschitzka F, Heart Failure ET(A) Receptor Blockade Trial: Hemodynamic and neurohumoral effects of selective endothelin A [ET(A)] receptor blockade in chronic heart failure: The Heart Failure ET(A) Receptor Blockade Trial (HEAT). Circulation 2002; 106: 2666-2672. (Pubitemid 35364920)
27. Matsumoto Y, Aihara H, Yamauchi-Kohno R, Reien Y, Ogura T, Yabana H, Masuda Y, Sato T, Komuro I, Nakaya H: Long-term endothelin A receptor blockade inhibits electrical remodeling in cardiomyopathic hamsters. Circulation 2002; 106: 613-619. (Pubitemid 34827713)
28. Rossi GP, Sacchetto A, Cesari M, Pessina AC: Interactions between endothelin-1 and the renin-angiotensin-aldosterone system. Cardiovasc Res 1999; 43: 300-307. (Pubitemid 29356368)
29. Shibata R, Ouchi N, Ito M, Kihara S, Shiojima I, Pimentel DR, Kumada M, Sato K, Schiekofer S, Ohashi K, Funahashi T, Colucci WS, Walsh K: Adiponectin-mediated modulation of hypertrophic signals in the heart. Nat Med 2004; 10: 1384-1389. (Pubitemid 40022722)
30. Shibata R, Sato K, Pimentel DR, Takemura Y, Kihara S, Ohashi K, Funahashi T, Ouchi N, Walsh K: Adiponectin protects against myocardial ischemia-reperfusion injury through AMPK-and COX-2-dependent mechanisms. Nat Med 2005; 11: 1096-1103. (Pubitemid 41486832)
31. Mouquet F, Cuilleret F, Susen S, Sautiere K, Marboeuf P, Ennezat PV, McFadden E, Pigny P, Richard F, Hennache B, Vantyghem MC, Bertrand M, Dallongeville J, Jude B, Van Belle E: Metabolic syndrome and collateral vessel formation in patients with documented occluded coronary arteries: Association with hyperglycaemia, insulin-resistance, adiponectin and plasminogen activator inhibitor-1. Eur Heart J 2009; 30: 840-849.
32. Ferrante G, Cosentino N, Barlis P, Niccoli G: Association of adiponectin with adverse outcome in coronary artery disease patients: Results from the AtheroGene study. Eur Heart J 2008; 29: 1922-1923; author reply 1923-1924.
33. Paakko T, Ukkola O, Ikaheimo M, Kesaniemi YA: Plasma adiponectin levels are associated with left ventricular hypertrophy in a random sample of middle-aged subjects. Ann Med 2010; 42: 131-137.
34. Ouchi N, Shibata R, Walsh K: Cardioprotection by adiponectin. Trends Cardiovasc Med 2006; 16: 141-146. (Pubitemid 43867326)